Zhong, Ruibo
Talebian, Sepehr http://orcid.org/0000-0002-4735-0986
Mendes, Bárbara B. http://orcid.org/0000-0001-8630-1119
Wallace, Gordon http://orcid.org/0000-0002-0381-7273
Langer, Robert http://orcid.org/0000-0003-4255-0492
Conde, João http://orcid.org/0000-0001-8422-6792
Shi, Jinjun http://orcid.org/0000-0001-9200-5068
Article History
Received: 6 January 2021
Accepted: 9 January 2023
First Online: 20 March 2023
Competing interests
: R.L. declares the following financial interests: Alnylam Pharmaceuticals, Inc. and Moderna, Inc. For a list of entities with which R.L. is involved, compensated or uncompensated, see the Supplementary Note. J.C. is a co-founder and shareholder of TargTex S.A. - Targeted Therapeutics for Glioblastoma Multiforme. The other authors declare no competing interests.
Free to read: This content has been made available to all.